Literature DB >> 20802517

DNA copy number aberrations in small-cell lung cancer reveal activation of the focal adhesion pathway.

S Ocak1, H Yamashita, A R Udyavar, A N Miller, A L Gonzalez, Y Zou, A Jiang, Y Yi, Y Shyr, L Estrada, V Quaranta, P P Massion.   

Abstract

Small-cell lung cancer (SCLC) is the most aggressive subtype of lung cancer in its clinical behavior, with a 5-year overall survival as low as 5%. Despite years of research in the field, molecular determinants of SCLC behavior are still poorly understood, and this deficiency has translated into an absence of specific diagnostics and targeted therapeutics. We hypothesized that tumor DNA copy number alterations would allow the identification of molecular pathways involved in SCLC progression. Array comparative genomic hybridization was performed on DNA extracted from 46 formalin-fixed paraffin-embedded SCLC tissue specimens. Genomic profiling of tumor and sex-matched control DNA allowed the identification of 70 regions of copy number gain and 55 regions of copy number loss. Using molecular pathway analysis, we found a strong enrichment in these regions of copy number alterations for 11 genes associated with the focal adhesion pathway. We verified these findings at the genomic, gene expression and protein level. Focal Adhesion Kinase (FAK), one of the central genes represented in this pathway, was commonly expressed in SCLC tumors and constitutively phosphorylated in SCLC cell lines. Those were poorly adherent to most substrates but not to laminin-322. Inhibition of FAK phosphorylation at Tyr(397) by a small-molecule inhibitor, PF-573,228, induced a dose-dependent decrease of adhesion and an increase of spreading in SCLC cell lines on laminin-322. Cells that tended to spread also showed a decrease in focal adhesions, as demonstrated by a decreased vinculin expression. These results support the concept that pathway analysis of genes in regions of copy number alterations may uncover molecular mechanisms of disease progression and demonstrate a new role of FAK and associated adhesion pathways in SCLC. Further investigations of FAK at the functional level may lead to a better understanding of SCLC progression and may have therapeutic implications.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20802517      PMCID: PMC4637980          DOI: 10.1038/onc.2010.362

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  46 in total

1.  Human small cell lung cancer cells express functional VEGF receptors, VEGFR-2 and VEGFR-3.

Authors:  Sachie Tanno; Yoshinobu Ohsaki; Kyoko Nakanishi; Eri Toyoshima; Kenjiro Kikuchi
Journal:  Lung Cancer       Date:  2004-10       Impact factor: 5.705

2.  A novel low-molecular weight inhibitor of focal adhesion kinase, TAE226, inhibits glioma growth.

Authors:  Qing Shi; Anita B Hjelmeland; Stephen T Keir; Linhua Song; Sarah Wickman; Dowdy Jackson; Osamu Ohmori; Darell D Bigner; Henry S Friedman; Jeremy N Rich
Journal:  Mol Carcinog       Date:  2007-06       Impact factor: 4.784

3.  Loss-of-heterozygosity analysis of small-cell lung carcinomas using single-nucleotide polymorphism arrays.

Authors:  K Lindblad-Toh; D M Tanenbaum; M J Daly; E Winchester; W O Lui; A Villapakkam; S E Stanton; C Larsson; T J Hudson; B E Johnson; E S Lander; M Meyerson
Journal:  Nat Biotechnol       Date:  2000-09       Impact factor: 54.908

4.  Epidermal growth factor receptor gene and protein and gefitinib sensitivity in non-small-cell lung cancer.

Authors:  Federico Cappuzzo; Fred R Hirsch; Elisa Rossi; Stefania Bartolini; Giovanni L Ceresoli; Lynne Bemis; Jerry Haney; Samir Witta; Kathleen Danenberg; Irene Domenichini; Vienna Ludovini; Elisabetta Magrini; Vanesa Gregorc; Claudio Doglioni; Angelo Sidoni; Maurizio Tonato; Wilbur A Franklin; Lucio Crino; Paul A Bunn; Marileila Varella-Garcia
Journal:  J Natl Cancer Inst       Date:  2005-05-04       Impact factor: 13.506

5.  Gene expression profiles of small-cell lung cancers: molecular signatures of lung cancer.

Authors:  Masaya Taniwaki; Yataro Daigo; Nobuhisa Ishikawa; Atsushi Takano; Tatsuhiko Tsunoda; Wataru Yasui; Kouki Inai; Nobuoki Kohno; Yusuke Nakamura
Journal:  Int J Oncol       Date:  2006-09       Impact factor: 5.650

Review 6.  Chromosomal imbalances in human lung cancer.

Authors:  Binaifer R Balsara; Joseph R Testa
Journal:  Oncogene       Date:  2002-10-07       Impact factor: 9.867

7.  Unbalanced chromosomal aberrations in neuroendocrine lung tumors as detected by comparative genomic hybridization.

Authors:  R Ullmann; A Schwendel; H Klemen; G Wolf; I Petersen; H H Popper
Journal:  Hum Pathol       Date:  1998-10       Impact factor: 3.466

8.  Chromosome alterations in human small cell lung cancer: frequent involvement of 5q.

Authors:  I Miura; S L Graziano; J Q Cheng; L A Doyle; J R Testa
Journal:  Cancer Res       Date:  1992-03-01       Impact factor: 12.701

9.  High resolution analysis of DNA copy number variation using comparative genomic hybridization to microarrays.

Authors:  D Pinkel; R Segraves; D Sudar; S Clark; I Poole; D Kowbel; C Collins; W L Kuo; C Chen; Y Zhai; S H Dairkee; B M Ljung; J W Gray; D G Albertson
Journal:  Nat Genet       Date:  1998-10       Impact factor: 38.330

10.  Mapping of multiple DNA gains and losses in primary small cell lung carcinomas by comparative genomic hybridization.

Authors:  T Ried; I Petersen; H Holtgreve-Grez; M R Speicher; E Schröck; S du Manoir; T Cremer
Journal:  Cancer Res       Date:  1994-04-01       Impact factor: 12.701

View more
  23 in total

1.  Separate enrichment analysis of pathways for up- and downregulated genes.

Authors:  Guini Hong; Wenjing Zhang; Hongdong Li; Xiaopei Shen; Zheng Guo
Journal:  J R Soc Interface       Date:  2013-12-18       Impact factor: 4.118

2.  Overexpression of focal adhesion kinase correlates with increased lymph node metastasis and poor prognosis in non-small-cell lung cancer.

Authors:  Hong-Fei Ji; Da Pang; Song-Bin Fu; Yan Jin; Lei Yao; Ji-Ping Qi; Jing Bai
Journal:  J Cancer Res Clin Oncol       Date:  2012-11-11       Impact factor: 4.553

3.  FAK Inhibition Decreases Hepatoblastoma Survival Both In Vitro and In Vivo.

Authors:  Lauren A Gillory; Jerry E Stewart; Michael L Megison; Hugh C Nabers; Elizabeth Mroczek-Musulman; Elizabeth A Beierle
Journal:  Transl Oncol       Date:  2013-04-01       Impact factor: 4.243

4.  Expression of focal adhesion kinase in small-cell lung carcinoma.

Authors:  Sebahat Ocak; Heidi Chen; Clay Callison; Adriana L Gonzalez; Pierre P Massion
Journal:  Cancer       Date:  2011-07-28       Impact factor: 6.860

5.  Pituitary adenylate cyclase-activating polypeptide causes increased tyrosine phosphorylation of focal adhesion kinase and paxillin.

Authors:  Terry W Moody; Julius Leyton; Robert T Jensen
Journal:  J Mol Neurosci       Date:  2011-09-06       Impact factor: 3.444

6.  Therapeutic Potential of Focal Adhesion Kinase Inhibition in Small Cell Lung Cancer.

Authors:  Frank Aboubakar Nana; Marylène Lecocq; Maha Zohra Ladjemi; Bruno Detry; Sébastien Dupasquier; Olivier Feron; Pierre P Massion; Yves Sibille; Charles Pilette; Sebahat Ocak
Journal:  Mol Cancer Ther       Date:  2018-10-23       Impact factor: 6.261

7.  FAK inhibition abrogates the malignant phenotype in aggressive pediatric renal tumors.

Authors:  Michael L Megison; Lauren A Gillory; Jerry E Stewart; Hugh C Nabers; Elizabeth Mrozcek-Musulman; Elizabeth A Beierle
Journal:  Mol Cancer Res       Date:  2014-01-24       Impact factor: 5.852

8.  FAK inhibition decreases cell invasion, migration and metastasis in MYCN amplified neuroblastoma.

Authors:  Michael L Megison; Jerry E Stewart; Hugh C Nabers; Lauren A Gillory; Elizabeth A Beierle
Journal:  Clin Exp Metastasis       Date:  2012-12-04       Impact factor: 5.150

9.  Proteomic Profiling Identifies PTK2/FAK as a Driver of Radioresistance in HPV-negative Head and Neck Cancer.

Authors:  Heath D Skinner; Uma Giri; Liang Yang; Sang Hyeok Woo; Michael D Story; Curtis R Pickering; Lauren A Byers; Michelle D Williams; Adel El-Naggar; Jing Wang; Lixia Diao; Li Shen; You Hong Fan; David P Molkentine; Beth M Beadle; Raymond E Meyn; Jeffrey N Myers; John V Heymach
Journal:  Clin Cancer Res       Date:  2016-04-01       Impact factor: 12.531

Review 10.  Epidemiology of lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines.

Authors:  Anthony J Alberg; Malcolm V Brock; Jean G Ford; Jonathan M Samet; Simon D Spivack
Journal:  Chest       Date:  2013-05       Impact factor: 9.410

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.